Announcement PDF 26 February 2014 Dear Shareholder Invion Limited Entitlement Offer – notice to eligible shareholders On 21 February, Invion Limited (Invion) announced the completion of a placement to institutional and professional investors to raise approximately AU$5 million (Institutional Placement), and a 1 for 20 nonrenounceable rights issue entitlement offer of fully paid ordinary shares in Invion (New Shares) to raise approximately AU$2 million (Entitlement Offer). Funds raised from the placement and rights issue will be applied to the collaboration with 3M Drug Delivery Systems to develop Invion’s inhaled respiratory drugs franchise, and continuing development of Invion’s three drug assets - INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirulkast), as well as general working capital. Patersons Securities Limited ACN 008 896 311 and Morgans Corporate Limited ABN 32 010 539 607 have been appointed as joint lead managers for the Equity Raising (JLMs). Summary of key terms of the Entitlement Offer Under the Entitlement Offer, Eligible Shareholders (defined below) will be invited to subscribe for 1 New Share for every 20 existing Invion ordinary shares held at 7.00pm (AEDT) on Thursday 6 March 2014 (Record Date) at an offer price of $0.075 per New Share (Entitlement). The Entitlement Offer is being made at the same offer price as the Institutional Placement. Eligibility of shareholders to participate in the Entitlement Offer You are being sent this letter because Invion believes you may be an Eligible Shareholder. An Eligible Shareholder means a holder of Invion Shares at 7.00pm (AEDT) on the Record Date who:  has a registered address in Australia and New Zealand or is a Shareholder that Invion has otherwise determined is eligible to participate; and  is eligible under all applicable securities laws to receive an offer under the Entitlement Offer without any requirement for a prospectus to be lodged or registered. The Entitlement Offer is being made by Invion without a disclosure document or product disclosure statement in accordance with section 708AA of the Corporations Act 2001 (Cth) (as notionally modified by ASIC Class Order 08/35). Shareholder approval is not required for Invion to make the offer under the Entitlement Offer. If you are not an Eligible Shareholder you cannot participate in the Entitlement Offer. Once the Record Date has passed, Invion will notify those shareholders who are not Eligible Shareholders. Further details about the Entitlement Offer Eligible Shareholders who take up their full Entitlement, may subscribe for additional New Shares from a pool of those not taken up by Eligible Shareholders as at the closing date of the Entitlement Offer (Top Up Facility). There is no guarantee that applicants under the Top Up Facility will receive the number of New Shares applied for under the Top Up Facility, or any. The Directors reserve the right to scale-back and allot and issue New Shares under the Top Up Facility at their discretion. Invion Limited ABN 76 094 730 417 GPO Box 1557, Brisbane, QLD, 4001. P +61 7 3295 0500 F +61 7 3295 0599 www.inviongroup.com The Directors also reserve the right, subject to the requirements of the Listing Rules and the Corporations Act 2001 (Cth), to place any shortfall shares remaining after the close of the Entitlement Offer (and completion of the Top Up Facility, if any), including those Entitlements of ineligible shareholders which were unable to be taken up under the Entitlement Offer, within 3 months after the closing date of the Entitlement Offer to either existing or new Shareholders at their discretion at a price not less than the Offer Price of New Shares under the Entitlements Offer. The Entitlement Offer is non-renounceable. Accordingly, Entitlements do not trade on the ASX, nor can they be transferred or otherwise disposed of. Fractional Entitlements will be rounded up to the nearest whole number of New Shares and holdings on different registers or sub-registers will not be aggregated to calculate Entitlements. Information Booklet An information booklet and personalised Entitlement and acceptance form will be issued to Eligible Shareholders after the Record Date which will set out the number of New Shares Eligible Shareholders are entitled to purchase under the Entitlement Offer. A copy of the information booklet is also available on the ASX website at www.asx.com.au and Invion’s website at www.inviongroup.com. Key dates Invion expects the Entitlement Offer to be conducted according to the following timetable. Event Date Announcement of Institutional Placement Friday, 21 February 2014 Announcement of Entitlement Offer Wednesday, 26 February 2014 Settlement of the Institutional Placement Wednesday, 26 February 2014 Allotment and trading of new shares issued under the Institutional Placement Thursday, 27 February 2014 ‘Ex’ date Friday, 28 February 2014 Record Date for determining Entitlements 7.00pm (AEDT) Thursday, 6 March 2014 Dispatch of Entitlement Offer information booklet to shareholders Monday, 10 March 2014 Entitlement Offer opens Tuesday, 11 March 2014 Entitlement Offer closes Tuesday, 25 March 2014 New Shares quoted on a deferred settlement basis Wednesday, 26 March 2014 Invion notifies ASX of under subscriptions Friday, 28 March 2014 Allotment of New Shares under the Entitlement Offer Wednesday, 2 April 2014 Normal trading of New Shares under the Entitlement Offer commences Thursday, 3 April 2014 Despatch of holding statements in respect of New Shares issued under the Entitlement Offer. Thursday, 3 April 2014 This Timetable is indicative only. The Directors may vary these dates, in consultation with the JLMs, subject to the Listing Rules. An extension of the closing date will delay the anticipated date for issue of the New Shares. The Directors also reserve the right not to proceed with the whole or part of the Entitlement Offer any time prior to allotment and issue of the New Shares. In that event, the relevant application monies (without interest) will be returned in full to applicants. Invion Limited ABN 76 094 730 417 GPO Box 1557, Brisbane, QLD, 4001. P +61 7 3295 0500 F +61 7 3295 0599 www.inviongroup.com Further information If you have any queries, please call 1300 910 051 (inside Australia) or +61 1300 910 051 (outside Australia), alternatively, consult your professional adviser. On behalf of the Directors, I thank you for your continued support of Invion. Yours sincerely Dr Greg Collier Managing Director & Chief Executive Officer Invion Limited ABN 76 094 730 417 GPO Box 1557, Brisbane, QLD, 4001. P +61 7 3295 0500 F +61 7 3295 0599 www.inviongroup.com